{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:49:54Z","timestamp":1759063794088,"version":"3.40.5"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Robert Koch-Institute, Berlin, Germany"},{"name":"German Federal Ministry of Health"},{"name":"Institute for Infection Medicine at Kiel"},{"name":"Excellence Cluster Inflammation at Interfaces"},{"name":"Institute of Clinical Molecular Biology"},{"name":"DFG Cluster of Excellence"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.antiviral.2018.02.004","type":"journal-article","created":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T08:12:56Z","timestamp":1517991176000},"page":"53-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Relevance of non-synonymous thymidine kinase mutations for antiviral resistance of recombinant herpes simplex virus type 2 strains"],"prefix":"10.1016","volume":"152","author":[{"given":"Anne-Kathrin","family":"Brunnemann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Deinhardt-Emmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1672-7840","authenticated-orcid":false,"given":"Claus-Henning","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruben","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Fickenscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Sauerbrei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andi","family":"Krumbholz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2018.02.004_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jcv.2017.10.002","article-title":"A European multi-centre External Quality Assessment (EQA) study on phenotypic and genotypic methods used for Herpes Simplex Virus (HSV) drug resistance testing","volume":"96","author":"Afshar","year":"2017","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2018.02.004_bib2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3851\/IMP1852","article-title":"Gene polymorphism of thymidine kinase and DNA polymerase in clinical strains of herpes simplex virus","volume":"16","author":"Bohn","year":"2011","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2018.02.004_bib3","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ijmm.2015.08.014","article-title":"Resistance testing of clinical herpes simplex virus type 2 isolates collected over 4 decades","volume":"305","author":"Bohn-Wippert","year":"2015","journal-title":"Int. J. Med. Microbiol."},{"year":"2016","series-title":"Aciclovir Resistance Phenotype of Clinical Isolates Proven by Targeted Mutagenesis of Recombinant Herpes Simplex and Varicella Zoster Viruses","author":"Brunnemann","key":"10.1016\/j.antiviral.2018.02.004_bib4"},{"key":"10.1016\/j.antiviral.2018.02.004_bib5","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1128\/AAC.05115-14","article-title":"Drug resistance of clinical varicella-zoster virus infections confirmed by recombinant thymidine kinase expression and by targeted resistance mutagenesis of a cloned clinical wild-type isolate","volume":"59","author":"Brunnemann","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.02.004_bib6","doi-asserted-by":"crossref","first-page":"29903","DOI":"10.1038\/srep29903","article-title":"Recombinant herpes simplex virus type 1 strains with targeted mutations relevant for acyclovir susceptibility","volume":"6","author":"Brunnemann","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2018.02.004_bib7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.antiviral.2013.09.012","article-title":"Surveillance of herpes simplex virus resistance to antivirals: a 4-year survey","volume":"100","author":"Burrel","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.02.004_bib8","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.antiviral.2012.09.016","article-title":"Impact of novel mutations of herpes simplex virus 1 and 2 thymidine kinases on acyclovir phosphorylation activity","volume":"96","author":"Burrel","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.02.004_bib9","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1128\/AAC.00669-10","article-title":"Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals","volume":"54","author":"Burrel","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.antiviral.2018.02.004_bib10","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1128\/AAC.49.7.2710-2715.2005","article-title":"Phenotyping of cytomegalovirus drug resistance mutations by using recombinant viruses incorporating a reporter gene","volume":"49","author":"Chou","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2A","key":"10.1016\/j.antiviral.2018.02.004_bib11","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/0002-9343(92)90329-A","article-title":"Mechanism of action of foscarnet against viral polymerases","volume":"92","author":"Crumpacker","year":"1992","journal-title":"Am. J. Med."},{"key":"10.1016\/j.antiviral.2018.02.004_bib12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1128\/JCM.42.1.242-249.2004","article-title":"Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up","volume":"42","author":"Danve-Szatanek","year":"2014","journal-title":"J. Clin. Microbiol."},{"issue":"1\u20132","key":"10.1016\/j.antiviral.2018.02.004_bib13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.vetmic.2010.02.014","article-title":"Herpesvirus systematics","volume":"143","author":"Davison","year":"2010","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.antiviral.2018.02.004_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3851\/IMP2533","article-title":"Selective anti-herpesvirus agents","volume":"23","author":"De Clercq","year":"2013","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2018.02.004_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.aids.0000198081.09337.a7","article-title":"Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies","volume":"20","author":"Freeman","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2018.02.004_bib16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jviromet.2017.10.019","article-title":"Application of next-generation sequencing to detect acyclovir-resistant herpes simplex virus type 1 variants at low frequency in thymidine kinase gene of the isolates recovered from patients with hematopoietic stem cell transplantation","volume":"251","author":"Fujii","year":"2018","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2018.02.004_bib17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1368-7646(02)00021-3","article-title":"Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms","volume":"5","author":"Gilbert","year":"2002","journal-title":"Drug Resist. Update"},{"key":"10.1016\/j.antiviral.2018.02.004_bib18","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1128\/JVI.50.3.733-738.1984","article-title":"Effects of deletions on expression of the herpes simplex virus thymidine kinase gene from the intact viral genome: the amino terminus of the enzyme is dispensable for catalytic activity","volume":"50","author":"Halpern","year":"1984","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.02.004_bib19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/QCO.0000000000000029","article-title":"Current thinking on herpes genitalis","volume":"27","author":"Hofstetter","year":"2014","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.02.004_bib20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1128\/CMR.00043-15","article-title":"Current concepts for genital herpes simplex virus infection: diagnostics and pathogenesis of genital tract shedding","volume":"29","author":"Johnston","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2018.02.004_bib21","first-page":"CS75","article-title":"Intravenous foscarnet in the management of acyclovir-resistant herpes simplex virus type 2 in acute retinal necrosis in children","volume":"11","author":"Khurana","year":"2005","journal-title":"Med. Sci. Monitor"},{"issue":"1","key":"10.1016\/j.antiviral.2018.02.004_bib22","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.virol.2003.09.033","article-title":"DNA immunization with a herpes simplex virus 2 bacterial artificial chromosome","volume":"318","author":"Meseda","year":"2004","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.antiviral.2018.02.004_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155531","article-title":"Prevalence of intrathecal acyclovir resistant virus in herpes simplex encephalitis patients","volume":"11","author":"Mitterreiter","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2018.02.004_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1386-6532(02)00263-9","article-title":"Herpes simplex virus resistance to antiviral drugs","volume":"26","author":"Morfin","year":"2003","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2018.02.004_bib25","first-page":"80","article-title":"Genetic characterization of herpes simplex virus type 2 UL23 thymidine kinase in Johannesburgh, South Africa","volume":"7","author":"Muller","year":"2013","journal-title":"J. Antivir. Antiretrovir."},{"issue":"1","key":"10.1016\/j.antiviral.2018.02.004_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/095632029700800101","article-title":"HPMPC (cidofovir), PMEA (adefovir) and related acyclic nucleoside phosphonate analogues: a review of their pharmacology and clinical potential in the treatment of viral infections","volume":"8","author":"Naesens","year":"1997","journal-title":"Antivir. Chem. Chemother."},{"issue":"6","key":"10.1016\/j.antiviral.2018.02.004_bib27","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1128\/JVI.02124-07","article-title":"Nuclear egress and envelopment of herpes simplex virus capsids analyzed with dual-color fluorescence HSV1(17+)","volume":"82","author":"Nagel","year":"2008","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.antiviral.2018.02.004_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064200","article-title":"A herpes simplex virus-derived replicative vector expressing LIF limits experimental demyelinating disease and modulates autoimmunity","volume":"8","author":"Nyg\u00e5rdas","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2018.02.004_bib29","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1128\/AAC.00615-10","article-title":"Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management","volume":"55","author":"Piret","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.02.004_bib30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/archinte.163.1.76","article-title":"Task Force on Herpes Simplex Virus. Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics","volume":"163","author":"Reyes","year":"2003","journal-title":"Arch. Int. Med."},{"key":"10.1016\/j.antiviral.2018.02.004_bib31","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJM199108223250805","article-title":"A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome","volume":"325","author":"Safrin","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2018.02.004_bib32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/IDR.S96164","article-title":"Optimal management of genital herpes: current perspectives","volume":"9","author":"Sauerbrei","year":"2016","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.antiviral.2018.02.004_bib33","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.3851\/IMP1870","article-title":"Novel resistance-associated mutations of thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 and type 2","volume":"16","author":"Sauerbrei","year":"2011","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2018.02.004_bib34","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/jac\/dkv285","article-title":"Database on natural polymorphisms and resistance-related non-synonymous mutations in thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 and 2","volume":"71","author":"Sauerbrei","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2018.02.004_bib35","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.antiviral.2010.03.002","article-title":"Phenotypic and genotypic characterization of acyclovir-resistant clinical isolates of herpes simplex virus","volume":"86","author":"Sauerbrei","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.02.004_bib36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.antiviral.2014.03.015","article-title":"Single nucleotide polymorphisms of tymidine kinase and DNA polymerase genes in clinical herpes simplex virus type 1 isolates associated with different resistance phenotypes","volume":"107","author":"Schubert","year":"2014","journal-title":"Antivir. Res."},{"issue":"9","key":"10.1016\/j.antiviral.2018.02.004_bib37","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1073\/pnas.080502497","article-title":"A self-recombining bacterial artificial chromosome and its application for analysis of herpesvirus pathogenesis","volume":"97","author":"Smith","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2018.02.004_bib38","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1086\/343739","article-title":"Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review","volume":"186","author":"Smith","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.antiviral.2018.02.004_bib39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2144\/000112096","article-title":"Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli","volume":"40","author":"Tischer","year":"2006","journal-title":"Biotechniques"},{"key":"10.1016\/j.antiviral.2018.02.004_bib40","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/978-1-60761-652-8_30","article-title":"En passant mutagenesis: a two step markerless red recombination system","volume":"634","author":"Tischer","year":"2010","journal-title":"Methods Mol. Biol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217307490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217307490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T20:01:51Z","timestamp":1603828911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354217307490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":40,"alternative-id":["S0166354217307490"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.02.004","relation":{},"ISSN":["0166-3542"],"issn-type":[{"type":"print","value":"0166-3542"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relevance of non-synonymous thymidine kinase mutations for antiviral resistance of recombinant herpes simplex virus type 2 strains","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}